Elevated concentrations of complement proteins have been found in the serum of patients with ovarian cancer (43), hepatitis C-associated hepatocellular cancer (44), pancreatic cancer (45), small cell renal carcinoma (46) and SCC (24). This evidence concerns the gene VTN and hepatocellular carcinoma.